Infectious Disease Clinical Trials
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Learn MoreWhere can I participate?
- Disease Type/ConditionHIV Infections
- Principal InvestigatorLaura Salazar
- Co-InvestigatorsJonathan Dau
- Age GroupAdult
- PhaseIII
- How do I learn more about this study?Laurie Hendricks, MSN, RN, OCN
laurie.hendricks@hoag.org